New Jersey S4123 requires involuntary commitment for individuals administered opioid antidotes for opioid overdoses.

New Jersey S4123 amends the law concerning involuntary commitment by expanding the definition of "dangerous to self" to include individuals who have been administered an opioid antidote for the emergency treatment of an apparent opioid overdose. The bill defines "opioid antidote" as naloxone hydrochloride or any similarly acting drug approved by the FDA for treating opioid overdoses. Under the bill, individuals who have recently been administered an opioid antidote are to be determined as dangerous to self. The act takes effect immediately.

New Jersey S4123 requires involuntary commitment for individuals administered opioid antidotes for opioid overdoses.

New Jersey S4123 amends the law concerning involuntary commitment by expanding the definition of "dangerous to self" to include individuals who have been administered an opioid antidote for the emergency treatment of an apparent opioid overdose. The bill defines "opioid antidote" as naloxone hydrochloride or any similarly acting drug approved by the FDA for treating opioid overdoses. Under the bill, individuals who have recently been administered an opioid antidote are to be determined as dangerous to self. The act takes effect immediately.